Epax is investing in a major upgrade to its main production facility, supporting both its drive to develop next-generation marine oil products, and its commitment to sustainability. The $10 million investment in the facility in Aalesund, Norway includes the construction of a new synthesis plant. It will use tailor-made Epax fractionation technology to gently modify fish oil and extract different fatty acids for bespoke nutrition productsy.

‍

Visit Nutraceutical Business Review to learn more (link opens in new tab)